FI850654L - Förfarande för framställning av terapeutiskt användbara pleuromutilinderivator - Google Patents
Förfarande för framställning av terapeutiskt användbara pleuromutilinderivatorInfo
- Publication number
- FI850654L FI850654L FI850654A FI850654A FI850654L FI 850654 L FI850654 L FI 850654L FI 850654 A FI850654 A FI 850654A FI 850654 A FI850654 A FI 850654A FI 850654 L FI850654 L FI 850654L
- Authority
- FI
- Finland
- Prior art keywords
- preparation
- therapeutically useful
- pleuromutilin derivatives
- pleuromutilin
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
- C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
- C07C323/59—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pyrrole Compounds (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI921848A FI88714C (sv) | 1984-02-17 | 1992-04-24 | Pleuromutilinderivat befrämjande tillväxt |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3405632 | 1984-02-17 | ||
DE19843405632 DE3405632A1 (de) | 1984-02-17 | 1984-02-17 | Neue pleuromutilinderivate, verfahren zu ihrer herstellung und ihre verwendung |
DE19843413708 DE3413708A1 (de) | 1984-04-12 | 1984-04-12 | Neue pleuromutilinderivate, verfahren zu ihrer herstellung und ihre verwendung |
DE3413708 | 1984-04-12 |
Publications (4)
Publication Number | Publication Date |
---|---|
FI850654A0 FI850654A0 (sv) | 1985-02-15 |
FI850654L true FI850654L (sv) | 1985-08-18 |
FI90414B FI90414B (sv) | 1993-10-29 |
FI90414C FI90414C (sv) | 1994-02-10 |
Family
ID=25818547
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI850654A FI90414C (sv) | 1984-02-17 | 1985-02-15 | Förfarande för framställning av terapeutiskt användbara pleuromutilinderivator |
Country Status (21)
Country | Link |
---|---|
US (1) | US4675330A (sv) |
EP (1) | EP0153277B1 (sv) |
JP (1) | JPH068278B2 (sv) |
KR (1) | KR920001990B1 (sv) |
AU (1) | AU585209B2 (sv) |
CA (1) | CA1249281A (sv) |
CY (1) | CY1565A (sv) |
DE (1) | DE3560511D1 (sv) |
DK (1) | DK164664C (sv) |
ES (1) | ES8606262A1 (sv) |
FI (1) | FI90414C (sv) |
GR (1) | GR850415B (sv) |
HK (1) | HK103690A (sv) |
HU (1) | HU194819B (sv) |
IE (1) | IE58232B1 (sv) |
IL (1) | IL74355A (sv) |
MY (1) | MY102919A (sv) |
NZ (1) | NZ211131A (sv) |
PH (1) | PH21588A (sv) |
PL (1) | PL145848B1 (sv) |
SG (1) | SG69290G (sv) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU208115B (en) * | 1989-10-03 | 1993-08-30 | Biochemie Gmbh | New process for producting pleuromutilin derivatives |
AT392272B (de) * | 1989-10-03 | 1991-02-25 | Biochemie Gmbh | Verfahren zur herstellung eines pleuromutilinderivats und seiner saeureadditionssalze |
AT400674B (de) * | 1991-07-24 | 1996-02-26 | Biochemie Gmbh | Pharmazeutische pleuromutilin-zubereitung |
AT397654B (de) * | 1992-05-04 | 1994-06-27 | Biochemie Gmbh | Neue pleuromutilinderivate, ihre verwendung und verfahren zu ihrer herstellung |
KR100516418B1 (ko) * | 1996-07-04 | 2005-12-20 | 바이오케미 게젤샤프트 엠베하 | 플루로뮤틸린유도체의수의학적용도 |
NO331772B1 (no) * | 1996-07-04 | 2012-03-26 | Biochemie Gmbh | Veterinaermedisinsk anvendelse av et pleuromutilinderivat |
GB9614017D0 (en) * | 1996-07-04 | 1996-09-04 | Biochemie Gmbh | Organic compounds |
UY25225A1 (es) * | 1997-10-29 | 2000-12-29 | Smithkline Beecham Plc | Derivados de pleuromutilina utiles como agentes antimicrobianos |
GB9918037D0 (en) * | 1999-07-30 | 1999-09-29 | Biochemie Gmbh | Organic compounds |
TWI260220B (en) * | 1999-11-22 | 2006-08-21 | Novartis Ag | A pharmaceutical composition for the transdermal treatment of bacterial infections in animals |
GB0017031D0 (en) * | 2000-07-11 | 2000-08-30 | Biochemie Gmbh | Antimicrobials |
PE20020676A1 (es) * | 2000-09-13 | 2002-08-27 | Biochemie Gmbh | Compuestos de mutilina como antibacterianos |
CO5390081A1 (es) | 2001-11-28 | 2004-04-30 | Novartis Ag | Compuestos organicos |
US20040116510A1 (en) * | 2002-03-05 | 2004-06-17 | Nichtberger Steven A. | Antihypertensive agent and cholesterol absorption inhibitor combination therapy |
GB0209262D0 (en) * | 2002-04-23 | 2002-06-05 | Biochemie Gmbh | Organic compounds |
GB0308114D0 (en) * | 2003-04-08 | 2003-05-14 | Glaxo Group Ltd | Novel compounds |
EP1686115A1 (de) * | 2005-01-26 | 2006-08-02 | Novartis AG | Organische Säureadditionssalze von Valnemulin |
GB0504314D0 (en) * | 2005-03-02 | 2005-04-06 | Glaxo Group Ltd | Novel polymorph |
CN101880252B (zh) * | 2010-06-29 | 2013-01-23 | 金河生物科技股份有限公司 | 盐酸沃尼妙林的制备方法 |
CN102229580B (zh) * | 2011-05-12 | 2014-02-26 | 南通大学 | 新型截短侧耳素衍生物、其制备方法及其医药用途 |
CN102344397B (zh) * | 2011-08-23 | 2013-09-04 | 浙江升华拜克生物股份有限公司 | 一种伐奈莫林盐酸盐的提纯方法 |
CN102424660B (zh) * | 2011-08-25 | 2013-11-27 | 浙江升华拜克生物股份有限公司 | 一种伐奈莫林盐酸盐的低温起泡干燥法及其干燥品 |
CN102675173B (zh) * | 2012-04-28 | 2013-12-11 | 武汉回盛生物科技有限公司 | 一种盐酸沃尼妙林的化学合成方法 |
CN103193692A (zh) * | 2013-04-23 | 2013-07-10 | 河北科技大学 | 一种沃尼妙林及其盐酸盐的制备 |
CN104311464A (zh) * | 2014-09-15 | 2015-01-28 | 河北威远动物药业有限公司 | 一种兽用沃尼妙林的制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4060542A (en) * | 1969-07-25 | 1977-11-29 | Biochemie Gesellschaft M.B.H. | 14-Desoxy-14 thiocyanato-acetoxy-mutilin |
US3919290A (en) * | 1972-10-03 | 1975-11-11 | Sandoz Ltd | Substituted 14-desoxy-mutilins |
US4086359A (en) * | 1975-09-30 | 1978-04-25 | E. R. Squibb & Sons, Inc. | Derivatives of pleuromutilin and compositions |
CH619450A5 (sv) * | 1976-01-15 | 1980-09-30 | Sandoz Ag | |
JPS54160358A (en) * | 1978-06-06 | 1979-12-19 | Sandoz Ag | Improvement for organic compound |
GB2072012B (en) * | 1980-03-14 | 1984-07-25 | Squibb & Sons Inc | Veterinary compositions containing pleuromutilin derivatives |
FR2526019A1 (fr) * | 1982-04-28 | 1983-11-04 | Sandoz Sa | Nouveaux derives de la pleuromutiline, leur preparation et leur utilisation comme medicaments |
-
1985
- 1985-02-11 EP EP85810049A patent/EP0153277B1/de not_active Expired
- 1985-02-11 DE DE8585810049T patent/DE3560511D1/de not_active Expired
- 1985-02-14 PH PH31854A patent/PH21588A/en unknown
- 1985-02-14 KR KR1019850000904A patent/KR920001990B1/ko not_active IP Right Cessation
- 1985-02-15 IL IL74355A patent/IL74355A/xx not_active IP Right Cessation
- 1985-02-15 AU AU38773/85A patent/AU585209B2/en not_active Expired
- 1985-02-15 NZ NZ211131A patent/NZ211131A/xx unknown
- 1985-02-15 IE IE37585A patent/IE58232B1/en not_active IP Right Cessation
- 1985-02-15 ES ES540464A patent/ES8606262A1/es not_active Expired
- 1985-02-15 CA CA000474419A patent/CA1249281A/en not_active Expired
- 1985-02-15 FI FI850654A patent/FI90414C/sv not_active IP Right Cessation
- 1985-02-15 HU HU85567A patent/HU194819B/hu unknown
- 1985-02-15 DK DK072885A patent/DK164664C/da not_active IP Right Cessation
- 1985-02-15 PL PL1985251972A patent/PL145848B1/pl unknown
- 1985-02-15 GR GR850415A patent/GR850415B/el not_active IP Right Cessation
- 1985-02-16 JP JP60029186A patent/JPH068278B2/ja not_active Expired - Lifetime
-
1986
- 1986-05-06 US US06/860,266 patent/US4675330A/en not_active Expired - Lifetime
-
1987
- 1987-09-29 MY MYPI87002186A patent/MY102919A/en unknown
-
1990
- 1990-08-22 SG SG692/90A patent/SG69290G/en unknown
- 1990-12-13 HK HK1036/90A patent/HK103690A/xx not_active IP Right Cessation
-
1991
- 1991-05-17 CY CY1565A patent/CY1565A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
AU3877385A (en) | 1985-09-12 |
DK164664C (da) | 1992-12-21 |
FI850654A0 (sv) | 1985-02-15 |
HU194819B (en) | 1988-03-28 |
CA1249281A (en) | 1989-01-24 |
ES8606262A1 (es) | 1986-04-16 |
KR920001990B1 (ko) | 1992-03-09 |
EP0153277B1 (de) | 1987-08-26 |
HUT39155A (en) | 1986-08-28 |
PL145848B1 (en) | 1988-11-30 |
IE850375L (en) | 1985-08-17 |
DK72885A (da) | 1985-08-18 |
IE58232B1 (en) | 1993-08-11 |
IL74355A (en) | 1988-04-29 |
DE3560511D1 (en) | 1987-10-01 |
DK164664B (da) | 1992-07-27 |
FI90414B (sv) | 1993-10-29 |
MY102919A (en) | 1993-03-31 |
CY1565A (en) | 1991-05-17 |
JPS60199870A (ja) | 1985-10-09 |
AU585209B2 (en) | 1989-06-15 |
JPH068278B2 (ja) | 1994-02-02 |
EP0153277A2 (de) | 1985-08-28 |
IL74355A0 (en) | 1985-05-31 |
ES540464A0 (es) | 1986-04-16 |
GR850415B (sv) | 1985-06-18 |
DK72885D0 (da) | 1985-02-15 |
HK103690A (en) | 1990-12-21 |
PL251972A1 (en) | 1985-12-03 |
US4675330A (en) | 1987-06-23 |
PH21588A (en) | 1987-12-11 |
FI90414C (sv) | 1994-02-10 |
EP0153277A3 (en) | 1985-09-25 |
NZ211131A (en) | 1988-08-30 |
KR850006938A (ko) | 1985-10-25 |
SG69290G (en) | 1990-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI850654L (sv) | Förfarande för framställning av terapeutiskt användbara pleuromutilinderivator | |
FI880941A (sv) | Förfarande för framställning av terapeutiskt användbara piperazinyl-heterocykliska föreningar | |
FI104170B1 (sv) | Förfarande för framställning av terapeutiskt användning 3-aminopyrazolderivat | |
FI874459A (sv) | Förfarande för framställning av terapeutiskt användbara piperidinderivat | |
PT81463B (pt) | Processo para a preparacao de novos derivados 5-amino-4-hidroxivalerilo | |
FI92696C (sv) | Förfarande för framställning av terapeutiskt användbara tiazolidindionderivat | |
ES539954A0 (es) | Procedimiento de preparacion de un derivado de ciano-2-ben- cimidazol | |
FI872517A (sv) | Förfarande för framställning av terapeutiskt användbara makrolidföreningar | |
FI883672A (sv) | Förfarande för framställning av terapeutiskt användbara aminoalkoxifenylderivat | |
FI891339A0 (sv) | Förfarande för framställning av nya terapeutiskt användbara aristeromycin/adenosinderivat | |
FI883889A0 (sv) | Förfarande för framställning av nya terapeutiskt användbara aristeromycin/adenosinderivat | |
ES548221A0 (es) | Un procedimiento para la produccion de un derivado de diami-das de n-acilaminoacidos | |
FI893936A0 (sv) | Förfarande för framställning av terapeutiskt aktiva föreningar samt mellanprodukter | |
FI893003A (sv) | Förfarande för framställning av terapeutiskt användbara neplanocinderivat | |
FI892948A0 (sv) | Förfarande för framställning av terapeutiskt användbara kromanderivat | |
FI95701C (sv) | Förfarande för framställning av terapeutiskt användbara kromanderivat | |
PT80264B (pt) | Processo para a preparacao de derivados de hidroxi-4-2h-1-benzotiopiran-2-onas | |
FI92064C (sv) | Förfarande för framställning av terapeutiskt användbara N-bensopyranyllaktamer | |
FI92825C (sv) | Förfarande för framställning av terapeutiskt användbara kromanderivat | |
FI911420A (sv) | Förfarande för framställning av terapeutiskt användbara föreningar | |
FI884473A (sv) | Förfarande för framställning av terapeutiskt användbara fenoxialkylpyrokatekolderivat | |
FI863471A0 (sv) | Förfarande för framställning av terapeutiskt användbara 3-desmetylmevalonsyraderivat | |
FI893434A (sv) | Förfarande för framställning av nya terapeutiskt användbara cykloalkyltiazolderivat | |
PT81487B (pt) | Processo para a preparacao de novos derivados de tienopiridina | |
FI92396B (sv) | Nytt förfarande för framställning av metylendioxifenantrenföreningar |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BB | Publication of examined application | ||
PC | Transfer of assignment of patent |
Owner name: NOVARTIS AG |
|
FG | Patent granted |
Owner name: NOVARTIS AG |
|
MA | Patent expired |